Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

NCT07392541 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Advanced Biliary Tract Carcinoma

Interventions

DRUG: Adebrelimab
DRUG: Gemcitabine + Cisplatin
DRUG: Simvastatin 20mg

Sponsor

Tongji Hospital